1. Home
  2. BGLC vs XAIR Comparison

BGLC vs XAIR Comparison

Compare BGLC & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.14

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.49

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
XAIR
Founded
2017
2011
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BGLC
XAIR
Price
$2.14
$0.49
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
2.1K
343.5K
Earning Date
04-14-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
62.09
EPS
N/A
N/A
Revenue
$7,424,911.00
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
N/A
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$1.92
$0.15
52 Week High
$15.19
$3.78

Technical Indicators

Market Signals
Indicator
BGLC
XAIR
Relative Strength Index (RSI) 40.46 33.95
Support Level $2.14 $0.43
Resistance Level $2.73 $0.82
Average True Range (ATR) 0.06 0.07
MACD 0.00 -0.00
Stochastic Oscillator 0.00 15.35

Price Performance

Historical Comparison
BGLC
XAIR

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: